US study raises doubts over ovarian cancer tests
This article was originally published in Clinica
Executive Summary
Two methods commonly used to screen women for ovarian cancer may also cause unnecessary surgery, due to the high level of false positive results caused by the tests. So found preliminary data from one of the largest screening trials of its kind - the PLCO Cancer Screening Trial - which was set up by the US National Cancer Institute (NCI) in 1993 to investigate the long-term benefit of cancer screening tests for prostate, lung, colorectal and ovarian cancer (PLCO).
You may also be interested in...
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.